Needham & Company Starts Genomic Health Inc. (GHDX) at Strong Buy

January 2, 2019 4:17 PM

Needham & Company analyst Stephen Unger initiates coverage on Genomic Health Inc. (NASDAQ: GHDX) with a Strong Buy rating and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found